loader
Please Wait
Applying Filters...

Looking for Tablet? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Acetone Excipient

02 1Acetyl Triethyl Citrate

03 1Acetyl tri-n-butyl citrate

04 1Acrylate copolymer

05 1Amino Methacrylate Copolymer

06 3Ammonia Methacrylate Copolymer Type A

07 1Ammonio Methacrylate Copolymer

08 4Ammonio Methacrylate Copolymer Type B

09 1Carbomer 941

10 4Carbomer Homopolymer Type A

11 1Carbomer Homopolymer Type B

12 1Copovidone K25-31

13 1Dibutyl Sebacate

14 1Ethyl Cellulose

15 3EthylCellulose

16 1HPMC 2910

17 2Hydrogenated Castor Oil

18 1Hydroxypropyl Betacyclodextrin

19 1Hydroxypropyl Methyl Cellulose

20 9Hydroxypropyl Methylcellulose

21 1Kaolin Excipient

22 1Lauryl Sulfate

23 1METHACRYLIC ACID COPOLYMER TYPE A

24 3Methacrylic Acid & Ethyl Acrylate Copolymer

25 5Methacrylic Acid - Ethyl Acrylate Copolymer

26 1Methacrylic Acid Copolymer Type B

27 2Methacrylic Acid Methyl Methacrylate Copolymer

28 3Microcrystalline Cellulose

29 1PLASACRYL HTP20

30 1PLASACRYL T20

31 2Phenylethyl Alcohol Excipient

32 1Poly DL Lactide

33 1Poly DL Lactide co Glycolide

34 2Poly L Lactide

35 1Poly-DL-Lactic-co-Glycolic Acid

36 1Polycarbophil

37 1Polydextrose Sugar

38 1Polyethylene Oxide

39 1Polyvinyl Acetate

40 3Polyvinyl Alcohol

41 1Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

42 1Potassium Chloride Excipient

43 2Povidone

44 1Sodium Alginate Excipient

45 2Sodium Citrate Dihydrate Excipient

46 1Sodium Hydroxide Excipient

47 1Starch

48 1Talc Excipient

49 1Tri-n-butyl Citrate

50 1Triethyl Citrate

51 1Xylitol Excipient

52 1hydroxypropyl methylcellulose phthalate

53 2polyethylene glycol

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

Brand Name : EUDRAGIT® E 100

Excipient Details : EUDRAGIT® E is an immediate-release polymer used as a taste masking & coating agent to improve swallowability of tablets, ODTs, capsules, powder, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® E 100

Applications : EUDRAGIT® E is an immediate-release polymer used as a taste masking & coating agent to improve swallowability of tablets, ODTs, capsules, powder, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

Grade : Oral

arrow

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral, Parenteral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Tablet

Category : Controlled & Modified Release

03

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

Brand Name : EUDRAGIT® L 100

Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® L 100

Applications : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Grade : Oral

arrow

05

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

Brand Name : EUDRAGIT® L 100-55

Excipient Details : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® L 100-55

Applications : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55

Grade : Oral

arrow

06

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

Brand Name : EUDRAGIT® RL 100

Excipient Details : EUDRAGIT® RL, an insoluble, highly permeable polymer used in combination with EUDRAGIT® RS in customized release drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® RL 100

Applications : EUDRAGIT® RL, an insoluble, highly permeable polymer used in combination with EUDRAGIT® RS in customized release drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO

Grade : Oral

arrow

07

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

Brand Name : EUDRAGIT® RS 100

Excipient Details : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as granules; Other grades- EUDRAGIT® RS 12,5, EUDRAGIT® RS 30 D, EUDRAGIT® RS PO

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® RS 100

Applications : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as granules; Other grades- EUDRAGIT® RS 12,5, EUDRAGIT® RS 30 D, EUDRAGIT® RS PO

Grade : Oral

arrow

08

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

Brand Name : EUDRAGIT® S 100

Excipient Details : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® S 12,5

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® S 100

Applications : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® S 12,5

Grade : Oral

arrow

09

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : PLASACRYL HTP20

Dosage Form : Tablet

Category : Controlled & Modified Release

10

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : PLASACRYL T20

Dosage Form : Tablet

Category : Controlled & Modified Release

11

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Ingredient(s) : Microcrystalline Cellulose

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : GELLETS-P®

Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

arrow

12

arrow
Fi Europe 2024
Not Confirmed

13

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

14

arrow
Fi Europe 2024
Not Confirmed

17

arrow
Fi Europe 2024
Not Confirmed

19

arrow
Fi Europe 2024
Not Confirmed

20

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank

21

arrow
Fi Europe 2024
Not Confirmed

22

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand Name : PLLA

Excipient Details : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

Grade : Oral, Parenteral

arrow

Brand : PLLA

Applications : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

Grade : Oral, Parenteral

arrow
blank

23

arrow
Fi Europe 2024
Not Confirmed

26

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand Name : PDLLA

Excipient Details : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

Grade : Oral, Parenteral

arrow

Brand : PDLLA

Applications : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

Grade : Oral, Parenteral

arrow
blank

30

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : ESPHERES EM

Applications : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

Pharmacopoeia Ref : Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

Technical Specs : Not Available

Grade : Oral

arrow
blank

31

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand Name : PLGA

Excipient Details : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

Grade : Oral, Parenteral

arrow

Brand : PLGA

Applications : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

Grade : Oral, Parenteral

arrow
blank

36

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
blank

37

arrow
Fi Europe 2024
Not Confirmed

41

arrow
Fi Europe 2024
Not Confirmed

46

arrow
Fi Europe 2024
Not Confirmed

52

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : CARBOPOL 971P NF

Applications : Carbopol® 971P NF polymer is used in oral & mucosal contact applications such as extended/controlled release tablets, oral liquids, suspension & bioadhesive formulations. The residual solvent of Carbopol 971P NF is Ethyl acetate.

Pharmacopoeia Ref : United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type A, European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) monographs for Carbomers.

Technical Specs : Viscosity, cP (0.5 wt% at pH 7.5)- 4,000 - 11,000

Grade : Oral & Topical

arrow
blank

54

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
blank

56

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand Name : Carbopol 974P NF

Excipient Details : Carbopol® 974P NF polymer is used in oral and mucosal contact applications such as oral liquids, bioadhesive formulations, & extended release tablets. Additionally, it can be used to formulate viscous gels, emulsions & suspensions.

Pharmacopoeia Ref : United States Pharmacopeia/Nat...

Technical Specs : Viscosity, cP (0.5 wt% at pH 7.5)- 29,400 - 39,400

Grade : Oral & Topical

arrow

Brand : CARBOPOL 974P NF

Applications : Carbopol® 974P NF polymer is used in oral and mucosal contact applications such as oral liquids, bioadhesive formulations, & extended release tablets. Additionally, it can be used to formulate viscous gels, emulsions & suspensions.

Pharmacopoeia Ref : United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type B, European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) mongographs for Carbomers.

Technical Specs : Viscosity, cP (0.5 wt% at pH 7.5)- 29,400 - 39,400

Grade : Oral & Topical

arrow
blank

57

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand Name : Noveon Polycarbophil

Excipient Details : Noveon® polycarbophil provides excellent bioadhesive properties & can be used for the formulation of buccal, nasal, ophthalmic, rectal bioadhesive products. lt can also be used as a controlled release polymer in oral solid dose applications.

Pharmacopoeia Ref : United States Pharmacopeia/Nat...

Technical Specs : Viscosity, cP (0.2 wt% at pH 7.5) - 2,000 - 12,000

Grade : Topical, Oral, Nasal & Ophthalmics

arrow

Brand : NOVEON POLYCARBOPHIL

Applications : Noveon® polycarbophil provides excellent bioadhesive properties & can be used for the formulation of buccal, nasal, ophthalmic, rectal bioadhesive products. lt can also be used as a controlled release polymer in oral solid dose applications.

Pharmacopoeia Ref : United States Pharmacopeia/National Formulary (USP/NF) monograph for Polycarbophil.

Technical Specs : Viscosity, cP (0.2 wt% at pH 7.5) - 2,000 - 12,000

Grade : Topical, Oral, Nasal & Ophthalmics

arrow
blank

73

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : ACRYPOL 971

Applications : It is widely used in oral solid, liquid dosage forms & topical formulations. It acts as excellent gel matrix former for controlling drug release in solid dosage forms.

Pharmacopoeia Ref : USP/NF : Carbomer Homopolymer Type A, EP : Carbomers

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

74

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : ACRYPOL 971G

Applications : It is widely used in oral solid, liquid dosage forms & topical formulations. It acts as excellent gel matrix former for controlling drug release in solid dosage forms.

Pharmacopoeia Ref : USP/NF: Carbomer Homopolymer Type A, EP : Carbomers

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

75

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : ACRYPOL 971P

Applications : It is widely used in oral solid, liquid dosage forms & topical formulations. It acts as excellent gel matrix former for controlling drug release in solid dosage forms.

Pharmacopoeia Ref : USP/NF : Carbomer Homopolymer Type A, EP : Carbomers

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

76

arrow
Fi Europe 2024
Not Confirmed

78

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : ACRYFLOW S

Applications : Lipophilic lubricant, Acryflow is used as an emulsifier for oil-in-water emulsions and as a pH independent sustained release agent. It acts as a plasticizer in solid dispersions.

Pharmacopoeia Ref : USP/NF: Hydrogenated Castor Oil EP: Castor Oil, Hydrogenated

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

84

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : KOLLICOAT SR 30 D

Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specs : Not Available

Grade : Not Available

arrow
blank